Albemarle Announces Sale of a Controlling Stake in Ketjen to KPS Capital Partners

Core Viewpoint - Albemarle Corporation has entered into a definitive agreement to sell a controlling stake in Ketjen Corporation's refining catalyst solutions business to KPS Capital Partners, while also selling its 50% interest in the Eurecat joint venture to Axens SA, expecting total pre-tax proceeds of approximately $660 million from both transactions [1][2][7]. Group 1: Transaction Details - Albemarle will retain a 49% stake in Ketjen after the transaction, while KPS will own 51% and have operational control [2][3]. - The completion of both transactions is anticipated in the first half of 2026, subject to customary closing conditions and regulatory approvals [2][7]. - The proceeds from these transactions are expected to be used for debt reduction and general corporate purposes [2]. Group 2: Strategic Rationale - The CEO of Albemarle expressed confidence in KPS's expertise in managing large manufacturing businesses, indicating a belief in Ketjen's growth potential under KPS's direction [3]. - The transactions align with Albemarle's strategic priorities to focus on core businesses, improve financial flexibility, and streamline operations [3]. Group 3: Company Background - Albemarle Corporation is a global leader in providing essential elements for mobility, energy, connectivity, and health, with a focus on lithium and bromine supply [4]. - Ketjen's refining catalyst solutions business serves global customers in 25 markets, providing advanced catalyst solutions for the petrochemical and refining industries [6].